Research Labs

Search by name:

Show search filters

Browse by last name:

Total: 182 Faculty Members

Omar I. Abdel-Wahab, MD

Human Oncology & Pathogenesis Program

Pictured: Abdel-Wahab Lab

Physician-scientist Omar Abdel-Wahab studies the functional genomics of hematopoietic malignancies.

Prasad S. Adusumilli, MD

Memorial Hospital Research Laboratories

Physician-scientist Prasad Adusumilli studies tumor immunology and the development of T-cell-mediated immunotherapy for thoracic malignancies and pleural-based diseases.

David Allis, MD

Molecular Biology Program

Molecular biologist C. David Allis investigates the histone code and its impact on gene regulation and chromosome dynamics.

Grégoire Altan-Bonnet, PhD

Computational Biology Program

Computational biologist Grégoire Altan-Bonnet focuses on probing and testing the integration of cellular activation that makes up the immune response.

Kathryn V. Anderson, PhD

Developmental Biology Program

Anderson lab

Developmental Biology Program Chair Kathryn Anderson studies genetic pathways that direct embryonic patterning and morphogenesis in the mouse embryo.

Cristina R. Antonescu, MD

Memorial Hospital Research Laboratories

The Antonescu Lab

Physician-scientist Cristina Antonescu studies the molecular pathogenesis of soft tissue sarcomas and gastrointestinal stromal tumors.

Scott A. Armstrong, MD, PhD

Cancer Biology & Genetics Program

Pictured: Scott Armstrong Lab

Physician-scientist Scott Armstrong focuses on defining genetic and epigenetic programs that control the extensive self-renewal properties associated with leukemia and other cancers.

Daniel Bachovchin, PhD

Chemical Biology Program

Chemical biologist Daniel Bachovchin designs selective inhibitors to study enzymes and pathways in cancer and immune system signaling.

Zhirong Bao, PhD

Developmental Biology Program

Developmental biologist Zhirong Bao investigates how the genome dictates development using C. elegans as a model.

José Baselga, MD, PhD

Human Oncology & Pathogenesis Program

Memorial Sloan Kettering Physician-in-Chief José Baselga studies mechanisms of resistance to targeted therapies and identification of novel therapeutic combinations in solid cancers.